Business Description
Aflac Inc
NAICS : 524114
SIC : 6321
Description
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.63 | |||||
| Equity-to-Asset | 0.19 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | 1.36 | |||||
| Interest Coverage | 24.35 | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5 | |||||
| 3-Year EBITDA Growth Rate | 14.8 | |||||
| 3-Year EPS without NRI Growth Rate | 19.2 | |||||
| 3-Year FCF Growth Rate | -1.3 | |||||
| 3-Year Book Growth Rate | 18 | |||||
| Future 3-5Y Total Revenue Growth Rate | -4.64 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.08 | |||||
| 9-Day RSI | 49.5 | |||||
| 14-Day RSI | 48.75 | |||||
| 6-1 Month Momentum % | 21.38 | |||||
| 12-1 Month Momentum % | 19.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.25 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| 3-Year Dividend Growth Rate | 8.3 | |||||
| Forward Dividend Yield % | 2.5 | |||||
| 5-Year Yield-on-Cost % | 3.51 | |||||
| 3-Year Average Share Buyback Ratio | 4.8 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 24.51 | |||||
| ROE % | 17.21 | |||||
| ROA % | 3.47 | |||||
| ROIC % | 3.9 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.46 | |||||
| Forward PE Ratio | 13.12 | |||||
| PE Ratio without NRI | 9.38 | |||||
| Shiller PE Ratio | 13.62 | |||||
| PEG Ratio | 1.12 | |||||
| PS Ratio | 2.33 | |||||
| PB Ratio | 1.92 | |||||
| Price-to-Tangible-Book | 1.9 | |||||
| Price-to-Free-Cash-Flow | 12.92 | |||||
| Price-to-Operating-Cash-Flow | 12.92 | |||||
| EV-to-EBIT | 8.83 | |||||
| EV-to-EBITDA | 8.83 | |||||
| EV-to-Revenue | 2.37 | |||||
| EV-to-Forward-Revenue | 2.59 | |||||
| EV-to-FCF | 13.05 | |||||
| Price-to-Projected-FCF | 0.59 | |||||
| Price-to-DCF (Earnings Based) | 0.51 | |||||
| Price-to-DCF (FCF Based) | 0.99 | |||||
| Price-to-Median-PS-Value | 1.62 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.89 | |||||
| Price-to-Graham-Number | 0.89 | |||||
| Earnings Yield (Greenblatt) % | 11.33 | |||||
| Forward Rate of Return (Yacktman) % | 20.59 |
